✦ LIBER ✦

FOLFIRINOX as second-line chemotherapy in patients with advanced pancreatic cancer who have progressed on gemcitabine-based therapy

✍ Scribed by Lee, M.G.; Lee, Sang Hyub; Hwang, J.H.; Ryu, J.K.; Kim, Y.T.; Kim, D.U.; Woo, S.M.

Book ID: 122256534
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 45 KB
Volume: 24
Category: Article
ISSN: 0953-6205
DOI: 10.1016/j.ejim.2013.08.361

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5-Fluorouracil/leucovorin combined with

5-Fluorouracil/leucovorin combined with irinotecan and oxaliplatin (folfirinox) as second-line chemotherapy in patients with advanced pancreatic cancer who have progressed on gemcitabine-based therapy

✍ Lee, Min Geun; Hwang, Jin-Hyeok; Ryu, Ji Kon; Kim, Yong-Tae; Kim, Dong Uk; Woo, 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 552 KB

Phase II study of flutamide as second li

Phase II study of flutamide as second line chemotherapy in patients with advanced pancreatic cancer

✍ Jivesh J. Sharma; Betty Razvillas; C.D. Stephens; Susan G. Hilsenbeck; Ashu Shar 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 37 KB

Taxol as Second-Line Treatment in Patien

Taxol as Second-Line Treatment in Patients with Advanced Ovarian Cancer after Platinum-Based First-Line Chemotherapy

✍ K. Mayerhofer; E. Kucera; H. Zeisler; P. Speiser; A. Reinthaller; P. Sevelda 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Impact of KRAS Mutations on Clinical Out

Impact of KRAS Mutations on Clinical Outcomes in Pancreatic Cancer Patients Treated with First-line Gemcitabine-Based Chemotherapy

✍ Kim, S. T.; Lim, D. H.; Jang, K.-T.; Lim, T.; Lee, J.; Choi, Y.-L.; Jang, H.-L.; 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 322 KB

A phase II trial evaluating capecitabine

A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3

✍ Alexandra Leary; L. Assersohn; D. Cunningham; A. R. Norman; G. Chong; G. Brown; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 310 KB

Conventional second-line salvage chemoth

Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens

✍ Kirit M. Ardeshna; Nicholaos Kakouros; Wendi Qian; Michael G. Powell; Nishaat Sa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB